Misratu Saka – Trademark Portfolio
Entity Type: 01
Misratu Saka holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 2 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include CURECHLY and LEVELS & GROWTH. The owner is based in Santa Clara, CA.
Santa Clara, CA 95054
Showing of trademarks Trademarks
Trademark Classifications
Misratu Saka's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Misratu Saka have?
Misratu Saka has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Misratu Saka file in?
Misratu Saka files trademarks across 4 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 44 (Medical Services). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.
What are Misratu Saka's most well-known trademarks?
Misratu Saka's registered trademark portfolio includes well-known marks such as CURECHLY and LEVELS & GROWTH. These are among 2 currently registered trademarks in the portfolio.
What is Misratu Saka's trademark registration success rate?
Misratu Saka has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.